XOMA is transitioning into a diversified royalty holding company, yet its financial performance remains heavily tethered to the unpredictable timing of milestone payments across its 70-asset portfolio.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q2 2026Latest May 12, 2026 | $0.17-10.5% vs $0.19 | $14M+0.3% vs $14M |
Q2 2026 Mar 18, 2026 | $0.26+300.0% vs -$0.13 | $14M+24.5% vs $11M |
Q4 2025 Nov 12, 2025 | $0.70+1850.0% vs -$0.04 | $9M-18.5% vs $11M |
Q3 2025 Aug 13, 2025 | $0.48+500.0% vs -$0.12 | $13M+39.9% vs $9M |
Ligand Pharmaceuticals NASDAQ: LGND outlined its royalty-focused growth strategy, recent XOMA acquisition and portfolio catalysts during a company presentation, highlighting a larger commercial-stage asset base and planned investment capacity.
Benchmark XOMA against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for XOMA Royalty Corp. (XOMA)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $40.17 | $503.77M | 27.51 | 83.06% | 60.81% | 34.12% | 0.76% | |
| $67.30 | $29.83B | 37.39 | 5.06% | 32.15% | 8.35% | 1% | |
| $3.61 | $250.51M | -1.14 | 105.77% | -169.75% | -26.02% | — | |
| $109.67 | $5.29B | 18.53 | 5.91% | 31.67% | 49.07% | 4.52% | |
| $18.28 | $2.3B | -5.56 | -4.26% | -386.32% | -87.98% | — | |
| $123.96 | $9.13B | -21.19 | — | — | -42.78% | — |
XOMA Royalty Corp. (XOMA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
XOMA Royalty Corp. (XOMA) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jul 14, 2026·SEC
Jun 12, 2026·SEC
May 22, 2026·SEC
Get notified when XOMA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
XOMA Royalty Corp. (XOMA) stock FAQ — growth, dividends, profitability & financials explained
XOMA Royalty Corp. (XOMA) reported $36.2M in revenue over the trailing twelve months. Revenue was $52.1M in fiscal year 2025. That is 1349% more than the $3.6M of fiscal year 1996.
XOMA Royalty Corp. (XOMA) grew revenue by 83.1% in fiscal year 2025, compared with the prior fiscal year.
Yes. XOMA Royalty Corp. (XOMA) earned $31.5M in net income over the trailing twelve months (a 87.0% net margin).
Yes. XOMA Royalty Corp. (XOMA) pays a dividend that yields 0.76% at the current price, a small yield.
XOMA Royalty Corp. (XOMA) had a return on equity (ROE) of 34.1% in fiscal year 2025. That is well above the market's typical 10-15%.
XOMA Royalty Corp. (XOMA) generated $6.6M in free cash flow over the trailing twelve months.
